| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e25c9a20ec728d82c2029125ae317982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0669f10ac82c082c17a3bf9d4a941b96 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48943723e8da9a596128f017025bece9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed5630f446c3c1803cae91b2362294a6 |
| publicationDate |
2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010285358-A |
| titleOfInvention |
Antihypertensive agent |
| abstract |
An object of the present invention is to provide an antihypertensive agent that exhibits a preferable antihypertensive action while suppressing a decrease in heart rate. An antihypertensive agent comprising a phthalide derivative represented by the following general formula (1) as an active ingredient. [Chemical 1] (In the general formula (1), R 1 to R 4 each independently represents one group selected from the group consisting of a hydrogen atom, a hydroxyl group and an alkoxy group.) [Selection] Figure 4 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107188875-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013035810-A |
| priorityDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |